Research & Literature

Variability of HHV8 LNA-1 Immunohistochemical Staining Across the 3 Histologic Stages of HIV-Associated Mucocutaneous Kaposi Sarcoma: Is There a Relationship to Patients' CD4 Counts?

Mohanlal RD, Pather S

The American Journal of dermatopathology 2015; (37(7)):530-4 doi:10.1097/DAD.0000000000000363.

KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation.

Kieffer-Kwon P, Happel C, Uldrick TS, et al.

PloS one 2015; (10(8)):e0135560 doi:10.1371/journal.pone.0135560.

Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

Schulz TF, Cesarman E

Current opinion in virology 2015; (14()):116-28.

Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection.

Fernández-Sánchez M, Iglesias MC, Ablanedo-Terrazas Y, et al.

AIDS (London, England) 2016; (30(6)):909-14 doi:10.1097/QAD.0000000000000993.

Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging.

Hernández-Sierra A, Rovira J, Petit A, et al.

Transplant international : official journal of the European Society for Organ Transplantation 2016; (29(9)):1008-16 doi:10.1111/tri.12800.

Evaluation of a Predictive Staging Model for HIV-Associated Kaposi Sarcoma in Uganda.

Okuku F, Krantz EM, Kafeero J, et al.

Journal of acquired immune deficiency syndromes (1999) 2017; (74(5)):548-554 doi:10.1097/QAI.0000000000001286.

A fifth subtype of Kaposi's sarcoma, classic Kaposi's sarcoma in men who have sex with men: a cohort study in Paris.

Denis D, Seta V, Regnier-Rosencher E, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2018; (32(8)):1377-1384 doi:10.1111/jdv.14831.

Evolution of Kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin.

Marcoval J, Bonfill-Ortí M, Martínez-Molina L, et al.

Clinical and experimental dermatology 2019; (44(1)):32-39 doi:10.1111/ced.13605.

Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.

Busakhala NW, Waako PJ, Strother MR, et al.

Journal of global oncology 2018; (4()):1-9 doi:10.1200/JGO.17.00077.

A Series of Patients with Kaposi Sarcoma (Mediterranean/Classical Type): Case Presentations and Short Update on Pathogenesis and Treatment.

Temelkova I, Tronnier M, Terziev I, et al.

Open access Macedonian journal of medical sciences 2018; (6(9)):1688-1693 doi:10.3889/oamjms.2018.354.

A retrospective review of patients with Kaposi's sarcoma in Botswana.

Slaught C, Williams V, Grover S, et al.

International journal of dermatology 2019; (58(6)):707-712 doi:10.1111/ijd.14305.

AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Reid E, Suneja G, Ambinder RF, et al.

Journal of the National Comprehensive Cancer Network : JNCCN 2019; (17(2)):171-189.

Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study.

Delyon J, Rabate C, Euvrard S, et al.

Journal of the American Academy of Dermatology 2019; (81(2)):448-455 doi:10.1016/j.jaad.2019.03.028.

A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma.

Ramaswami R, Uldrick TS, Polizzotto MN, et al.

Clinical cancer research : an official journal of the American Association for Cancer Research 2019; (25(14)):4238-4247 doi:10.1158/1078-0432.CCR-18-3528.

A case of mistaken identity: classic Kaposi sarcoma misdiagnosed as a diabetic foot ulcer in an atypical patient.

Torrence GM, Wrobel JS

Clinical diabetes and endocrinology 2019; (5()):8 doi:10.1186/s40842-019-0083-x.

An unusual series of patients with Kaposi sarcoma.

Wang J, Reid H, Klimas N, Koshelev M

JAAD case reports 2019; (5(8)):646-649 doi:10.1016/j.jdcr.2019.05.016.

Kaposi Sarcoma Updates.

Etemad SA, Dewan AK

Dermatologic clinics 2019; (37(4)):505-517 doi:10.1016/j.det.2019.05.008.

Update on oncogenesis and therapy for Kaposi sarcoma.

Dupin N

Current opinion in oncology 2020; (32(2)):122-128 doi:10.1097/CCO.0000000000000601.

Gastric Ulcer as Presentation of HIV-Associated Kaposi Sarcoma and Resolution With HAART Therapy.

Nassri R, Muftah A, Muftah M, et al.

ACG case reports journal 2019; (6(10)):e00262 doi:10.14309/crj.0000000000000262.

Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.

Poizot-Martin I, Obry-Roguet V, Duvivier C, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(5)):1065-1073 doi:10.1111/jdv.16204.

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.

Krown SE, Moser CB, MacPhail P, et al.

Lancet (London, England) 2020; (395(10231)):1195-1207 doi:10.1016/S0140-6736(19)33222-2.

Pulmonary Kaposi's Sarcoma - Initial Presentation of HIV Infection

Komitova R, Chudomirova K, Abadjieva T

Folia medica 2019; (61(4)):643-649 doi:10.3897/folmed.61.e47945.

Primary penile Kaposi's sarcoma in HIV-seronegative patient: a case report and literature review.

Cito G, Di Costanzo R, Morselli S, et al.

International braz j urol : official journal of the Brazilian Society of Urology 2020; (46(5)):825-842 doi:10.1590/S1677-5538.IBJU.2020.05.03.

Disseminated Kaposi's sarcoma as a presenting sign of HIV in an Indian male: A case report with dermoscopic findings.

Prabhakaran N, Gupta D, Chandrashekhar L, et al.

Indian journal of sexually transmitted diseases and AIDS 2020; (41(1)):102-105 doi:10.4103/ijstd.IJSTD_53_16.

A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma.

Séverin D, Bessaoud F, Meftah N, et al.

AIDS (London, England) 2021; (35(3)):399-405 doi:10.1097/QAD.0000000000002744.

Beyond T Staging in the "Treat-All" Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa.

Freeman EE, Semeere A, McMahon DE, et al.

Journal of acquired immune deficiency syndromes (1999) 2021; (87(5)):1119-1127 doi:10.1097/QAI.0000000000002699.

Cyclosporine-Induced Kaposi Sarcoma in a Patient With Ulcerative Colitis.

Clarke LM, Chawla K, Tabbara N, et al.

ACG case reports journal 2021; (8(5)):e00600 doi:10.14309/crj.0000000000000600.

Posttransplant Kaposi sarcoma: Analysis of a series of 13 patients.

González-Cruz C, Ferrándiz-Pulido C, Ferrer Fàbregas B, García-Patos Briones V

Medicina clinica 2021; (157(7)):339-343 doi:10.1016/j.medcli.2021.04.030.

[A new form of Kaposi sarcoma].

Derickx LAJ, Houwing RH, van Bergen BH, et al.

Nederlands tijdschrift voor geneeskunde 2021; (165()).

Management of Vascular Sarcoma.

Subramaniam A, Giani C, Napolitano A, et al.

Surgical oncology clinics of North America 2022; (31(3)):485-510 doi:10.1016/j.soc.2022.03.014.

Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis.

Freeman EE, McCann NC, Semeere A, et al.

The Lancet. Global health 2022; (10(8)):e1179-e1188 doi:10.1016/S2214-109X(22)00242-X.

Herpesvirus-induced spermidine synthesis and eIF5A hypusination for viral episomal maintenance.

Choi UY, Lee JJ, Park A, et al.

Cell reports 2022; (40(7)):111234 doi:10.1016/j.celrep.2022.111234.

A Case of Non-cutaneous Kaposi Sarcoma.

Osei N, Fletcher G, Showunmi A, Ahluwalia M

Cureus 2022; (14(12)):e32394 doi:10.7759/cureus.32394.

Endemic Kaposi's Sarcoma.

Zeinaty PE, Lebbé C, Delyon J

Cancers 2023; (15(3)) doi:10.3390/cancers15030872.

A description of Kaposi sarcoma risk factors and outcomes in HIV-positive and HIV-negative patients at a tertiary care medical center from 2005 to 2020.

Libson K, Himed S, Dunlop H, et al.

Archives of dermatological research 2023; (315(7)):2159-2162 doi:10.1007/s00403-023-02552-2.

AIDS-Related Kaposi Sarcoma Associated with Steroid-Unresponsive Periorbital Lymphedema that Responded to Chemotherapy.

Zeng Y, Prasad R, King RD, et al.

The American journal of case reports 2023; (24()):e938801 doi:10.12659/AJCR.938801.

Lymphedema and Kaposi sarcoma: A narrative review.

Dauguet M, Lebbé C, Vignes S

Journal de medecine vasculaire 2023; (48(5-6)):181-187 doi:10.1016/j.jdmv.2023.10.007.

Kaposi Sarcoma of the Nail Unit: A Case Report and Review of the Literature.

Krygier J, Sass U, Meiers I, et al.

Skin appendage disorders 2023; (9(6)):465-469 doi:10.1159/000532114.

Evaluating Kaposi Sarcoma in Kidney Transplant Patients: A Systematic Review and Meta-Analysis.

Saowapa S, Polpichai N, Siladech P, et al.

Cureus 2024; (16(1)):e52527 doi:10.7759/cureus.52527.

Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi's Sarcoma Patients in South Africa.

Tibenderana RM, Blumenthal MJ, Bukajumbe E, et al.

Viruses 2024; (16(2)) doi:10.3390/v16020189.

Kaposi's Sarcoma. A Case Report.

Polách O, Kopecký A, Wandrolová Z, et al.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 2024; (80(2)):114-118 doi:10.31348/2024/16.

Electrochemotherapy in Kaposi's Sarcoma Patients: From the Gold Standard Strategy to Locally Advanced Cutaneous and Subcutaneous Lesions.

Rullo V, Castellaneta F, D'Antonio S, et al.

Cancers 2024; (16(7)) doi:10.3390/cancers16071295.

Kaposi Sarcoma Mimicking a Lingual Lesion in an HIV-Negative Patient: A Case Report.

Andrade-Carmona VR, Carmona-Araiza LG, Soria-Cespedes D, et al.

Cureus 2024; (16(3)):e57131 doi:10.7759/cureus.57131.

Prognostic factors in Kaposi sarcoma, single centre experience.

Değerli E, Oruç K, Şentürk Öztaş N, et al.

The Australasian journal of dermatology 2024; (65(5)):444-450 doi:10.1111/ajd.14309.

Pleural Kaposi Sarcoma in Two HIV-Positive Patients.

Abou Hamdan D, Hayek G, Abi Hanna P, et al.

Cureus 2024; (16(7)):e64938 doi:10.7759/cureus.64938.

[Clinical, demographic and histopathological characteristics of individuals with Kaposi's sarcoma and living with HIV in Mexico].

Lomelí-Canedo M, Pizano-Márquez BG, Magaña-García M

Revista medica del Instituto Mexicano del Seguro Social 2024; (62(6)):1-8.

De Novo Kaposi Sarcoma in an HIV-Negative Liver Transplant Recipient With Ulcerative Colitis and Primary Sclerosing Cholangitis.

Ramakrishnan P, Amin K, Gaertner W, Aby ES

Case reports in transplantation 2024; (2024()):4699128 doi:10.1155/crit/4699128.

Kaposi's sarcoma immune reconstitution inflammatory syndrome: A forgotten entity nowadays.

Cristina FR, Lorena VC, Tamara FS, et al.

Indian journal of sexually transmitted diseases and AIDS 2024; (45(2)):151-154 doi:10.4103/ijstd.ijstd_57_24.

Cardiac Kaposi Sarcoma Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome: A Case Report.

Dagher AB, Lee J, Cunningham HE, et al.

Cureus 2025; (17(1)):e76972 doi:10.7759/cureus.76972.

Colon ulcers and HIV: an image to remember.

Gómez Perosanz R, Quiñones Calvo M

Revista espanola de enfermedades digestivas 2025; (117(10)):609-610 doi:10.17235/reed.2025.11078/2025.

Fifth subtype of Kaposi sarcoma in HIV-negative MSM: a retrospective single-arm cohort study from a tertiary care center in NYC from 2000 to 2022.

Morales AE, Benson G, Glavan S, et al.

The oncologist 2025; (30(3)) doi:10.1093/oncolo/oyaf024.

Modern Approach to Manage Patients With Kaposi Sarcoma.

Bettuzzi T, Lebbe C, Grolleau C

Journal of medical virology 2025; (97(3)):e70294 doi:10.1002/jmv.70294.

Electrochemotherapy for cutaneous Kaposi Sarcoma: A European register-based cohort study from the International Network for Sharing Practices of electrochemotherapy (InspECT).

Quaglino P, Brizio M, Bertino G, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(8)):110099 doi:10.1016/j.ejso.2025.110099.

Hemophagocytic lymphohistiocytosis syndrome (HLH) in HIV-associated Kaposi sarcoma patients: The first case series from a single center in Türkiye.

Orta Z, Benli A, Çağatay AA, et al.

International journal of STD & AIDS 2025; (36(13)):946-950 doi:10.1177/09564624251355834.

Laser Therapy Approaches in the Treatment of Kaposi's Sarcoma: A Comprehensive Review of Dermatologic Options.

Battilotti C, Cassalia F, Svara F, et al.

Dermatology practical & conceptual 2025; (15(3)) doi:10.5826/dpc.1503a5332.

The Origin of Kaposi's Sarcoma and Other KSHV-Associated Sarcomas.

Yuan Y, Ding Y

Journal of medical virology 2025; (97(11)):e70675 doi:10.1002/jmv.70675.

Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon.

Nasir MW, Gao Y

Journal of medical virology 2025; (97(11)):e70695 doi:10.1002/jmv.70695.

Cost-effectiveness protocol for treating adult HIV-infected patients with Kaposi sarcoma in resource-limited settings: a phase III, randomized, open-label, non-inferiority study of paclitaxel and pegylated liposomal doxorubicin.

Chapola JC, Kleber SL, Krown SE, Painschab M

Cost effectiveness and resource allocation : C/E 2025; (23(1)):78 doi:10.1186/s12962-025-00677-x.

Kaposi Sarcoma: A Case of Mistaken Identity in an Immunocompetent Healthy Male.

Staab E, Reyes DC, Georgesen C, Menning M

European journal of case reports in internal medicine 2025; (12(12)):005879 doi:10.12890/2025_005879.

Iatrogenic Kaposi Sarcoma Revealed by Acral Nodules With Silent Pulmonary Involvement in Two Patients Treated for Autoimmune Blistering Diseases.

Zemmez Y, Zegmout A, Toufgua Z, et al.

Cureus 2025; (17(12)):e99633 doi:10.7759/cureus.99633.

Kaposi Sarcoma: Retrospective Clinical Analysis with a Focus on Age and HIV Serostatus.

Erçin Z, Toprak M

Viruses 2026; (18(1)) doi:10.3390/v18010144.